Regulators Aim to Enhance Diversity in Clinical Trials

Regulators from multiple regions respond to the global push to improve diversity in clinical trial enrollment.

Efforts to boost diversity in clinical trials are gaining traction worldwide, with significant attention paid to enhancing the representativeness of participant enrollment. The Pink Sheet reached out to regulators in the UK, EU, Canada, Australia, and Japan to uncover their actions and strategies aimed at supporting and ensuring diverse enrollment in clinical trials.

In recent years, there has been a growing recognition of the need for more inclusive clinical trials to ensure that new drugs and treatments are effective across different demographic groups. This has led to regulatory bodies prioritizing policies and initiatives that advocate for diversity and inclusivity in trial populations. This shift not only reflects a commitment to public health but also aligns with broader societal calls for equity in medical research.

Regulators from different regions have expressed their ongoing commitment to this goal, outlining specific measures and frameworks they are implementing to address the issue. Collaborative steps among international regulatory bodies also indicate a unified effort to tackle this challenge globally. These steps are essential in mitigating long-standing discrepancies in healthcare outcomes and ensuring that clinical research is applicable to a more representative section of the global population.

65

Impact Score

IBM and AMD partner on quantum-centric supercomputing

IBM and AMD announced plans to develop quantum-centric supercomputing architectures that combine quantum computers with high-performance computing to create scalable, open-source platforms. The collaboration leverages IBM´s work on quantum computers and software and AMD´s expertise in high-performance computing and Artificial Intelligence accelerators.

Qualcomm launches Dragonwing Q-6690 with integrated RFID and Artificial Intelligence

Qualcomm announced the Dragonwing Q-6690, billed as the world’s first enterprise mobile processor with fully integrated UHF RFID and built-in 5G, Wi-Fi 7, Bluetooth 6.0, ultra-wideband and Artificial Intelligence capabilities. The platform is aimed at rugged handhelds, point-of-sale systems and smart kiosks and offers software-configurable feature packs that can be upgraded over the air.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.